Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection

Advanced Drug Delivery Reviews(2023)10.1016/j.addr.2023.115009Source: DataRank Database

Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection is a research paper published in Advanced Drug Delivery Reviews (2023). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 8.74)OA: bronzeTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Brady Sillman ORCID,Mahmudul Hasan ORCID,Suyash Deodhar ORCID,Srijanee Das ORCID,Ashrafi Sultana ORCID

Live enrichment

PubMed:37451501 OpenAlex:https://openalex.org/W4384023277

National Institutes of Health

Grant: R01 AI158160

National Institutes of Health

Grant: R01 AI145542

National Institutes of Health

Grant: R01 MH115860

National Institutes of Health

Grant: R01 NS034239

National Institutes of Health

Grant: R01 NS036126

National Institutes of Health

Grant: R01 NS126089

FWCI

8.74

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S0169409X23003241-ga1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S0169409X23003241-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S0169409X23003241?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X23003241?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.addr.2023.115009

Fields of Study

HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment

MeSH Terms

RilpivirineFemaleHumansInjectionsHIV-1HIV InfectionsAnti-HIV Agents

Keywords

MedicineDosingIntensive care medicineRegimenAntiretroviral therapyHuman immunodeficiency virus (HIV)RilpivirineVaginal ringPharmacologyInternal medicineViral loadImmunologyPopulationFamily planningPharmacodynamicsHuman immunodeficiency virusAdverse ReactionsNucleoside Reverse Transcriptase InhibitorsPre-exposure ProphylaxisIntegrase Strand Transfer InhibitorsNonnucleoside Reverse Transcriptase InhibitorsLong-acting Slow Effective Release Antiretroviral TherapyMedicinal And Polymer ChemistryAntiretroviral ProdrugsPharmacokinetic Testing

Sustainable Development Goals

SDG 0: Good health and well-being